Hill Holler

Raw Political Coverage and Opinions

Good personal health is a basic requirement for all human beings. However, a large part of the world’s population gives little or no attention to their health until it is too late. Diseases associated with the heart are fatal and when not spotted in their early stages can be catastrophic. Unfortunately, only a few people have the motivation of visiting a cardiologist for a periodic checkup. It is not until their hearts are racing hysterically or is experiencing a sharp gnawing pain in their chests that they rush for medical care.

A cardiologist is a medical practitioner who focuses on diagnostic and treatment of the heart and the diseases affecting blood vessels. Simply put, this is a specialist in the cardiovascular system. However, the field is quite broad and it involves specialists like pediatric and clinical cardiologists. Luckily, New York City is graced with a good number of these experts.

Clinical cardiologists specialize in adult cardiology and are tasked with the duty of diagnosing and treating heart problems in adults. On the other hand, pediatric cardiologists treat cardiovascular diseases in children. Despite being in the same line of study, these two categories of medical professionals take different training directions.

In general, a cardiologists’ scope of work is quite extensive, and it is in their line of work to perform cardiac electrophysiology, echocardiography, interventional cardiology, and nuclear cardiology. Moreover, it still is also in their job description to insert stents and pacemakers in the heart.

Cardiology visits are beneficial to anyone dealing with a heart condition. For starters, the cardiologist is bound to evaluate your symptoms and medical history as a basis for more advanced tests for definite diagnosis. Once analyzed, the specialist can opt to put you under medication or any other treatment option if the condition is manageable. If not, then the cardiologist can refer you to a cardiovascular surgeon but still under his watchful eye.

It is important to note that cardiologist visits are not entirely for those with heart conditions. These medical experts in NYC recommend that people from all walks of life should schedule an appointment for examination regularly in order to maintain excellent cardiovascular health. They assist you to discover the risk factors instigating heart disease and go the extra mile to present you with measures to undertake for better health.

Dr. Edward Honig is a leading specialist in this field. He is a specialist in Internal Medicine practicing as the Managing Director of Cardiology at Glen Cove Hospital, NYC. He is a licensed physician by the New York State Medical License Board. He attended his higher education at Duke University Medical School.

Dr. Edward Honig is rated as one of the best cardiologists in NY. In the coveted list of heart specialists in the institution, he is recognized as the finest of the lot with a 93% experience match. His medical practice history is clean with no issues of malpractice, sanctions, or board actions, which has led to the awarding with the Healthgrades Honor Roll.

Even though he is not a public figure, Dr. Honig reputation has traveled far and wide. People who have had an encounter with him sing his praises. Hence, if you are an NYC resident, do not hesitate to visit the state’s finest, Dr. Honig, for better heart health.

Doctors at Cancer Treatment Centers of America will now have easy access to the most up-to-date, relevant research for each individual patient’s condition through a tool called Clinical Pathways. There is an overwhelming amount of medical research being published every day. Clinical Pathways intelligently combines the latest cancer research, treatment regimens, and complementary therapies for each patient’s unique condition. This provides oncologists with highly customized care options that they can combine with their own expertise and understanding of the patient’s history to provide a superior standard of care.

Clinical Pathways is designed with the patient in mind. The platform allows the doctors at Cancer Treatment Centers of America to provide:

  • Custom treatment plans
  • Instant comparisons between options, including average patient costs
  • Digital order entry
  • Integrated medical plans including supportive therapies as well as main treatments
  • Access to the latest treatment guidelines and risks

Overall, Clinical Pathways will make the excellent care provided at Cancer Treatment Centers of America even more efficient and effective for patients. Clinical Pathways is now available in the treatment of every patient at all five Cancer Treatment Centers of America locations.

Cancer Treatment Centers of America is headquartered in Boca Raton, FL and has five hospitals throughout the USA in Atlanta, GA, Chicago, IL, Philadelphia, PA, Phoenix, AZ and Tulsa, OK. CTCA has a reputation for attentive and personalized patient care for adults facing cancer diagnoses. CTCA’s integrative approach combines the latest advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, along with evidence-based supportive therapies to treat patients physically and emotionally.

For the most up to date information on Cancer Treatment Centers of America on Twitter.

In any business, it is imperative to become the dominant force in whatever market one is participating. This is especially true in businesses that require a high level of capital infrastructure in order to compete. Businesses like medicine, airlines and the pharmaceutical industry require such large amounts of capital that it would be foolish for anyone to attempt to compete in these well established markets.

CEO Clay Siegall understands this better than anyone. As the head of his own company, Seattle Genetics, Dr. Siegall has long sought to blaze new trails in the area of targeted cancer therapies. Assiduously avoiding those markets that have already been dominated by other pharmaceutical companies, Dr. Siegall has focused instead on cancer types that have not seen significant mortality improvement over the last 30 years. This has led him to create some of the most innovative drug types ever seen in the cancer treatment industry.

Through the introduction of antibody drug conjugates, a class of targeted cancer therapy that uses synthetic human antibodies to deliver extremely lethal cytotoxins directly to the site of malignant tissues, Dr. Siegall is making serious inroads into increasing the survivability of cancer types that have been stagnant set the 1970s. One of these cancer types is non-Hodgkins lymphoma, a lymphatic system disorder that affects up to 500,000 people in the United States alone at any given time.

Although non-Hodgkin’s lymphoma is less deadly than many other types of cancer, it affects so many people that it leads to thousands of deaths each year in the United States. However, the disease has not seen significant improvements in the mortality rate since the 1970s, leading Dr. Siegall to focusing on this disease as an ideal test bed for his highly innovative new class of drugs, antibody drug conjugates.

In 2011, Seattle Genetics was granted the first full FDA approval for a antibody drug conjugate, ADCetris. This miracle drug has been approved for treatment of refractory non-Hodgkin’s lymphoma. Dr. Siegall believes that within a few years it will also be fully approved by the nation’s primary drug regulatory agency for use as a front-line treatment and not only non-Hodgkin’s lymphoma but also a wide range of other cancer types.

Amicus Therapeutics has its headquarters office in Cranbury, New Jersey. The international headquarters office of Amicus is located in the United Kingdom. The other locations of Amicus Therapeutics are located in France, Germany, Italy, Netherlands, and Spain. It became a publicly traded company in 2007. The stock symbol of Amicus is FOLD. Amicus is traded on the NASDAQ market. The company was established in February 4, 2002. John F. Crowley has been the CEO of Amicus Therapeutics since 2005. Bradley Campbell is the Chief Operating Officer. William “Chip” Baird is the Chief Financial Officer. As of December 31, 2013, there were 92 employees at Amicus Therapeutics (YahooFinance).

 

The therapies offered by this pharmaceutical company focus on the care of rare and orphan diseases, such as lysosomal storage disorders (LSDs). SD-101 was developed for the treatment of Epidermolysis Bullosa (EB), a rare tissue disease that causes skin blistering. Migalastat was created for treating Fabry disease. It stabilizes the alpha-Gal A produced in the patient’s cells so it can be moved to the lysosomes. When it gets to the lysosomes, the GL-3 could be reduced. The brand name for Migalastat is Galafold. In order to develop enzyme replacement technologies(ERTs), Amicus Therapeutics leverages the Chaperone-Advanced Replacement Therapy (CHART) technology. Also, CHARTs are used to make ATB200/AT222, a treatment method consisting of a recombinant human acid alpha-glucosidase (rhGAA) enzyme. Therefore, Pompe disease can be treated with ATB200/AT222 because the deficiency of GAA is eliminated with rhGAA enzymes. As of right now, Amicus Therapeutics is discovering a new protein replacement therapy for CDKL5 (cyclin-dependent kinase-like 5) deficiency.

 

The company uses contractors for manufacturing because it is not an independent manufacturer. Amicus Therapeutics bought Callidus Biopharma in November 2013 (https://forexwizard.biz/2017/09/15/amicus-therapeutics/). As a result of the acquisition, Amicus had access to proprietary items and intellectual property that would be useful for the enzyme replacement technology used in treating Pompe Disease. The company made another acquisition in September 2015. This time it bought Scioderm for $947 million. CabaRare is a festival hosted by Amicus to celebrate RareDisease day. Performers with rare diseases participate in this festival.

More on Twitter

People don’t understand arthritis. It is a pervasive health problem, and it affects more and more people. However, it is not just one single disease. There are more than a hundred types, but osteoarthritis is one of the most common. It affects the joints and slowly destroys the soft tissue between the bones. Cartilage slowly deteriorates as well, and then bones start rubbing against each other. It slowly happens over time and impacts lifestyle and movement ability.

 

Osteo Relief Institute unites several hospitals that have specialists and researchers who want to educate people about arthritis. They also provide treatment options as well (Blog). There is no cure for osteoarthritis, but there are options for pain management available for the patients. Osteo Relief Institute also emphasizes that there are also exercise options for people to help them manage the pain.

 

There are several reasons people acquire this kind of issue. The researchers in the Osteo Relief Institute say that the causes can be inherited, genetic or naturally acquired over time. Individuals who are overweight, for example, have a higher possibility of suffering from arthritis. It has an impact on physical options as well as self-esteem and the quality of life in general.

Osteo Relief Institute suggests to exercise and monitor your weight. Don’t sit or stand for extended periods of time in the same position and move around when possible. Even stopping smoking can have an impact on putting off osteoarthritis.

 

If you suffer from this disease, one of the ways that can improve your life is having surgery in one of the hospitals of the Osteo Relief Institute. It will help you gain your confidence back, but the recovery process will be not easy.

 

Modern technology and research are on the mission to make this kind of surgery as less invasive as possible, but so far there are no permanent solutions. The research is still going on, and researchers are positive that this work has to continue. The hospitals provide patient care, information and they are located in large cities. The more people learn about the disease and the ways to put it off and manage it, the easier it becomes.

 

 

A craft beer refers to beer that is brewed in a traditional non-mechanized method in a small brewery. What makes craft beer differ and somewhat special than regular beer is, regular beer is prepared to be as profitable as possible to the brewery. It is also made in such a way that it ought to appeal to many in taste. Craft beer, on the other hand, is a form of art, in that, the artist prepares the beer out of the love of it. Regardless of it turning out mild or extreme, its main purpose is to be as original in taste and flavor as possible.

 

Eli Gershkovitch is the CEO of Steamworks Brewery and Companies, a craft beer microbrewery in Canada. He developed the passion in craft beer while he was on a European tour. Eli Gershkovitch had just graduated from the University of Toronto. He had studied law and was an aspiring young lawyer.

 

Eli Gershkovitch first tasted craft beer in Belgium. This made him have a desire to create something great that would satisfy his life. From his law office in Vancouver, Eli Gershkovitch kept researching on craft beer business and came across a perfect location in Gastown to put up a brewpub.

 

When people talk about Canada, few of them relate the country to craft beer (https://thereisnoconsensus.com/lawyer-eli-gershkovitch/). Eli Gershkovitch put Canada on the craft beer map with his creations of exciting new pilsners, lagers, and ales that are only found in Canada. He has been cooking up extraordinary beer flavors from this historic brewery in Gastown since 1995.

The consumption of craft beer continues to be on the increase around the world. Huge brewery corporates like Miller Brewing Company and Budweiser keep losing popularity by the day. While microbreweries like Eli Gershkovitch’s continue enjoying an increase in profits. It is still unclear how this is possible, though some say the rise in the cosmopolitan culture is to blame. Nonetheless, Eli Gershkovitch continues to use both traditional and innovative business methods to stay ahead of his competition. His focus is on the production of high-quality products, at pocket-friendly prices, and produce products that will meet his customers’ demands. His business model has managed to keep Steamworks afloat since its conception.

 

The effectiveness and efficiency of Big Data in the technological world are well-known today, and it is used in various industries to improve productivity and performance. Moreover, it is helping corporate, industrial, and the manufacturing units to improve accuracy in their output and planning.

In the transportation department, one of the most significant KPI or the key performance indicator is the on-time performance. It is what the Big Data helps in making visible to see which department needs to be further optimized (https://www.crunchbase.com/organization/edisoft). With the help of Big Data the variety of transport, such as air, sea, rail, and motor carriers were measured for their performance and scheduling accuracy.

Thanks to the evolution of technology and data availability, it is possible today for the fulfillment of the transportation systems to be measured and optimized accordingly. However, the on-time performance recorded and reported of most of the transport carriers tend to be inaccurate, and mostly because all the factors that need to be considered are not taken into account. In most cases, when it is reported that the on-time performance of a carrier is 99 percent, it is assumed that the performance is top notch.

However, it needs to be understood that in many cases only sixty to seventy percent of the shipment delivery is taken into account. The on-time performance requires a comprehensive data set to create key performance indicator figure, and in most cases, it is not available (Bloomberg). Most of the companies have a tough time linking all the data related to big data in a collaborative manner. However, it can be duly noted that the applications of big data are far reaching and not limited to only measuring carrier performances in the transportation sector.

Edisoft Inc is a technology firm based in Toronto, ON, and provides the configurable smart process supply chain service platform. It helps in improving the supply chain performance for the distributors as well as manufacturers. The best part about Edisoft is that it uses big data in its technology to offer warehouse and carrier management, and optimized vendor compliance integrated the system. Edisoft offers its products and services worldwide. It has headquarters in Toronto, ON, Canada, and a satellite office in Miami, FL, United States.

Glen Wakeman is someone who has exhibited high versatility, switching from the executive world to the start-up and entrepreneurship world smoothly. He has been highly successful as an entrepreneur, investor, writer, financial services executive, and mentor. Glen Wakeman has a lengthy successful career as an entrepreneur and teacher with admirable achievements that are unrivaled. His success, however, can be dated to way before he became the entrepreneur that he is today.

 

The foundation for a successful career was laid in 1981, where he graduated from the University of Scranton with a BSc in Economics and Finance and going on to get his MBA in Finance at the University of Chicago in 1993. Glen Wakeman started his successful career as a financial services executive starting with a position at GE Capital where he spent over two decades in various complex leadership roles in management and business development. After serving with excellence and delivering tangible results, he moved on to become the CEO, President of Doral Financial Corporation (DFC) and Board Chairman at Doral Bank. At these positions, he was credited with transforming DFC from a weak position to a strong position as a community bank receiving various awards for his leadership and excellence.

 

Glen Wakeman went on to start a business accelerator, Nova Four, which gives strategic advice and grants access to capital for start-ups. He is the President of Nova Four (Facebook). LaunchPad is the current company he founded to also help start-up growth. The company provides a fully automated SAAS that allows start-ups to breakdown ideas into a workable plan.

 

Glen’s Wakeman career has featured work like new market entry, divestitures, start-ups and so much more. He has a methodology he employs based on five performance points: Execution, Governance, Human Capital, Risk Management, and Leadership. He continues to contribute to small companies and start-ups as a writer, investor, and a mentor. He acts in an advisory role to start-ups like Sitter Bees and Dreamfunded.

 

He’s well-traveled (having lived in 6 different countries), well-versed in business and well recognized internationally for his highly successful business executive career and entrepreneurial pursuits. Glen Wakeman is the founder of Nova Four, which has helped and created other great minds in the entrepreneur business.

 

More about Glen Wakeman on https://www.linkedin.com/in/glen-wakeman-8b504b14

An affiliate of the Dallas-focused investment firm, Highland Capital Management, LP, the counterpart, Highland Capital Management recently closed a massive deal that focuses on healthcare private equity funds. This venture totals $147 million in commitments and the main investor is South Korea’s National Pension Service. Beginning in 1988, the NPS is currently valued at 565 trillion dollars. Another investor, the Sovereign Wealth Fund Institute reports that they are worth an impressive $465 billion.

Very specific details are outlined in this venture and are agreed upon amongst investors. Strategic business objectives for Korea, the United States as well as China are in place and other investment opportunities are also an option. This is the first time that Highland Capital Management has embarked on a healthcare-focused venture dealing with private equity. Up until now, investments were made from direct funds or from multi-purpose funds.

Carl Moore is the managing director for Highland Capital’s private equity group and he feels that the strategy associated with fund placement has been well planned out. With the firm being as experienced as it is within the health care sector, this is the perfect industry to target. The majority of targeted healthcare companies are currently located in Asia as well as North America.

Highland Capital Management currently has $15 billion in AUM with a large focus in credit strategies, hedge funds, private equity in distressed and special situation forms. Alternative investments are also an option along with long equities, short equities, natural resources and also emerging market funds.

In 2007, somewhere in Redwood City, California, John Danner and Preston Smith joined forces to create what’s now known as one of the pioneers of forging personalized lessons from customized educational software, standard technological devices, and top-notch educators that are skilled in crafting these lessons around students at an individual level. This system of public charter schools is better known as Rocketship Education, the system that has 18 locations around the United States, after its first year spent in a church in San Jose.

As Preston Smith has extensive experience in teaching kids from low-income areas, whose families have little disposable income to fork over to private schools that provide top-tier educations, he’s given back to these low-income, in-need communities by placing Rocketship Education facilities in such areas. The catch? Families that are poverty stricken don’t have to pay a single cent to enroll their children in any of Rocketship Education’s 18 locations. After its first ten years of operation, modern-day CEO Preston Smith was privy to tons of knowledge he otherwise would have never learned about. In May, earlier this year, he wrote an article that detailed several of these tidbits. Here are some of the most important.

Some babies are born with developmental disabilities. Some are visible from the moment they’re born, although may of them aren’t recognizable until they attend school, getting in trouble for bad behavior, not learning as easily as most other students, and a variety of other manifestations. Rocketship Education places students with special needs in general classrooms for a goal of 80% of their hours spent at each school day. This goal is referred to as the meaningful inclusion model of education.

Parents are encouraged to found educational institutions of their own. Preston Smith did exactly this after three years’ time as an educator in San Jose. Banding together a group of parents, school administrators, and fellow educators, he was able to found an independent public school in eight months. It’s possible for other parents, too.

Teachers are asked to visit parents’ homes once a year, creating better personalized learning plans.